Study guide

5.3 Surgical Wounds, Infections & Tetanus Prophylaxis

Clinical Officers Council Pre-Internship Examination Kenya

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview & Exam Strategy

1.1 About the COC Pre-Internship Examination 1.2 Clinical Decision-Making & Preparation Strategy

2 Chapter 2: Infectious & Communicable Diseases (Internal Medicine)

2.1 Malaria Diagnosis & Case Management 2.2 Tuberculosis & Leprosy Control 2.3 HIV/AIDS & Opportunistic Infections 2.4 Enteric & Neglected Tropical Infections

3 Chapter 3: Cardiovascular & Respiratory Medicine (Internal Medicine)

3.1 Hypertension & Cardiovascular Disorders 3.2 Respiratory Disorders & Acute Emergencies 3.3 Venous Thromboembolism & Vascular Emergencies

4 Chapter 4: Metabolic, Gastrointestinal & Neurological Medicine (Internal Medicine)

4.1 Diabetes Mellitus & Endocrine Emergencies 4.2 Gastrointestinal & Hepatorenal Disorders 4.3 Neurological Emergencies & Acute Toxicology

5 Chapter 5: Trauma Resuscitation & Emergency Surgery (General Surgery)

5.1 ATLS Primary Survey & Trauma Resuscitation 5.2 Burn Assessment & Fluid Resuscitation 5.3 Surgical Wounds, Infections & Tetanus Prophylaxis

6 Chapter 6: Acute Abdomen & Gastrointestinal Surgery (General Surgery)

6.1 Acute Appendicitis & Peritonitis 6.2 Intestinal Obstruction & Abdominal Hernias 6.3 Hepatobiliary, Pancreatic & Anorectal Surgical Conditions

7 Chapter 7: Orthopedics, Urology & Special Surgical Emergencies (General Surgery)

7.1 Fractures, Dislocations & Cast Management 7.2 Acute Compartment Syndrome & Limb Emergencies 7.3 Urological Emergencies & Pelvic Trauma 7.4 Emergency Airway, Anesthesia & Oncology Screening

8 Chapter 8: Essential Newborn Care & Neonatal Conditions (Pediatrics)

8.1 Immediate Newborn Care & Neonatal Resuscitation 8.2 Neonatal Jaundice, Sepsis & Common Disorders 8.3 Low Birth Weight & Kangaroo Mother Care

9 Chapter 9: IMCI Guidelines & Common Pediatric Conditions (Pediatrics)

9.1 IMCI Principles & General Danger Signs 9.2 Cough, Fast Breathing & Pediatric Pneumonia 9.3 Pediatric Diarrheal Diseases & Dehydration 9.4 Acute Pediatric Infections: Meningitis, Croup & Febrile Seizures

10 Chapter 10: Child Nutrition, KEPI & Preventive Pediatrics (Pediatrics)

10.1 Severe Acute Malnutrition (SAM) Management 10.2 KEPI Immunization Schedule & Vaccine Logistics 10.3 Pediatric Prophylaxis & Early Infant Diagnosis

11 Chapter 11: Antenatal Care & Medical Complications of Pregnancy (Obstetrics & Gynecology)

11.1 Focused Antenatal Care & Routine ANC Screening 11.2 Hypertensive Disorders of Pregnancy & Eclampsia 11.3 Medical Disorders & Infections in Pregnancy

12 Chapter 12: Labor, Delivery & Obstetric Emergencies (Obstetrics & Gynecology)

12.1 Normal Labor & Partograph Monitoring 12.2 Active Management of the Third Stage of Labor & PPH 12.3 Antepartum Hemorrhage & Uterine Rupture 12.4 Induction of Labor & Malpresentation Emergencies

13 Chapter 13: Puerperium, Gynecological Disorders & Family Planning (Obstetrics & Gynecology)

13.1 Puerperal Sepsis & Postnatal Complications 13.2 Pelvic Inflammatory Disease & Gynecological Conditions 13.3 Modern Contraceptive Technology & WHO MEC Criteria

14 Chapter 14: Primary Health Care & Devolved Health Systems (Community Health)

14.1 Primary Health Care Principles & Universal Health Coverage 14.2 Kenya Health Service Delivery Structure & Devolved Governance 14.3 Kenya Community Health Strategy & Level 1 Services

15 Chapter 15: Epidemiology, Disease Surveillance & Outbreak Response (Community Health)

15.1 Epidemiological Principles & Health Indicators 15.2 Integrated Disease Surveillance and Response (IDSR) 15.3 Vector Control & Neglected Tropical Diseases

16 Chapter 16: Environmental Health, Waste Management & Cold Chain (Community Health)

16.1 Water Quality & Household Water Treatment 16.2 Community Sanitation & Excreta Disposal 16.3 Healthcare Waste Management & Infection Prevention Control 16.4 Vaccine Cold Chain Management & Quality Monitoring

17 Chapter 17: Health Systems Management — Leadership, Policy & Financing

17.1 Management Functions, Leadership & Supportive Supervision 17.2 Kenya Health Policy, Planning & the Devolved Budget Cycle 17.3 Health Financing & Universal Health Coverage under the Social Health Authority 17.4 Human Resource Management, Scheme of Service & Performance Appraisal

18 Chapter 18: Health Commodities, Information & Quality Management

18.1 Health Commodity & Supply Chain Management (KEMSA) 18.2 Health Information Systems, Records & KHIS Reporting 18.3 Quality Improvement, Clinical Audit & Patient Safety

19 Chapter 19: Professional Practice, Ethics & Medico-Legal Responsibility

19.1 Scope of Practice, Registration, Licensing & Professional Discipline 19.2 Medical Ethics, Informed Consent & Patient Rights 19.3 Medico-Legal Documentation, Statutory Notification & Facility Safety Governance

5.3 Surgical Wounds, Infections & Tetanus Prophylaxis

Key Takeaways Explain This Topic AI

Surgical wounds are classified into four distinct classes: Clean (Class I, < 2% infection rate), Clean-contaminated (Class II, 3–8%), Contaminated (Class III, 10–15%), and Dirty-infected (Class IV, > 20% to 40%), dictating prophylactic versus therapeutic antibiotic administration.

Surgical Site Infection (SSI) prevention demands strict adherence to evidence-based bundles: preoperative chlorhexidine-alcohol skin preparation, electrical hair clipping without razor shaving, antimicrobial prophylaxis administered within 60 minutes prior to incision, and intraoperative normothermia and glycemic maintenance.

Postoperative fever follows the classic temporal timeline ('The 5 Ws'): Day 1–2 Wind (Atelectasis), Day 3 Water (Urinary Tract Infection), Day 5 Wound (Surgical Site Infection), Day 7 Walking (Deep Vein Thrombosis / Thromboembolism), and Day > 7 Wonder Drugs (Drug-induced fever).

Surgical Site Infections typically present on postoperative days 5 to 7; management requires mechanical wound opening, purulent evacuation, tissue debridement, and secondary-intention healing rather than relying solely on systemic antibiotics.

Tetanus prophylaxis is determined by wound risk stratification (clean minor vs tetanus-prone) and immunization status; patients with contaminated/tetanus-prone wounds and incomplete (< 3 doses) or unknown vaccination history must receive BOTH Tetanus Toxoid vaccine and Tetanus Immunoglobulin (TIG 250–500 IU IM) in separate syringes at distinct anatomical sites.

Last updated: September 2026

5.3 Surgical Wounds, Infections & Tetanus Prophylaxis

Core Clinical Rule: In surgical wound management, antibiotic prophylaxis can never compensate for poor surgical technique, tissue devitalization, or inadequate wound debridement. When post-operative fever manifests on postoperative Day 5, evaluate the wound directly: the treatment of a surgical site infection is mechanical drainage and opening of the wound , not escalating systemic antibiotics. In tetanus prophylaxis, whenever a patient presents with a tetanus-prone/contaminated wound and an incomplete (< 3 doses) or unknown immunization history , you must administer both Tetanus Toxoid (TT/Td) and Tetanus Immunoglobulin (TIG) using separate syringes at separate anatomical sites .

Surgical site infections (SSIs) represent the most frequent nosocomial infection among surgical patients across sub-Saharan Africa, prolonging hospital stays, escalating healthcare expenditures, and driving surgical mortality. Concurrently, traumatic wounds contaminated by soil or animal feces carry high lethality if tetanus prophylaxis protocols are breached. Mastering surgical wound classification, postoperative fever differential diagnosis, and evidence-based tetanus prevention is foundational for clinical officers practicing in district and referral hospitals.

1. Surgical Wound Classification & Infection Prevention Bundles

The CDC and American College of Surgeons (ACS) classify surgical wounds based on the intrinsic degree of microbial contamination at the time of operation. This classification predicts the baseline risk of surgical site infection and dictates the appropriate antibiotic strategy.

Wound Class Definition & Criteria Clinical Examples Expected SSI Rate Antibiotic Strategy

Class I: Clean Uninfected operative wound in which no inflammation is encountered; the respiratory, alimentary, genital, or uninfected urinary tracts are not entered ; closed primarily. Elective inguinal hernia repair with mesh, thyroidectomy, total mastectomy, elective lipoma excision < 2 % < 2\% < 2% Prophylactic antibiotics generally not indicated unless prosthetic material/mesh is implanted.

Class II: Clean-Contaminated Operative wound in which the respiratory, alimentary, genital, or urinary tract is entered under controlled conditions without unusual contamination or significant spillage. Elective cholecystectomy, elective appendectomy, planned small bowel resection, elective hysterectomy 3 % 3\% 3% to 8 % 8\% 8% Single-dose IV antimicrobial prophylaxis within 60 minutes prior to surgical incision.

Class III: Contaminated Open, fresh accidental wounds ( < 4 hours < 4\text{ hours} < 4 hours old); operations with major breaks in sterile technique; gross spillage from the gastrointestinal tract; or incisions encountering acute non-purulent inflammation. Penetrating abdominal trauma with enterotomy, open fracture < 4 hours < 4\text{ hours} < 4 hours , acute gangrenous non-perforated appendicitis, gross bile spillage during cholecystectomy 10 % 10\% 10% to 15 % 15\% 15% Prophylactic/preemptive IV antibiotics ; therapeutic coverage continued if contamination is severe.

Class IV: Dirty / Infected Old traumatic wounds with retained devitalized tissue, foreign bodies, or delayed treatment ( > 4 to 6 hours > 4\text{ to } 6\text{ hours} > 4 to 6 hours ); operations involving existing clinical infection or perforated viscera . Perforated appendicitis with fecal peritonitis, drained intra-abdominal abscess, delayed open fractures, debridement of Fournier's gangrene 20 % 20\% 20% to > 40 % > 40\% > 40% Full therapeutic course of IV antibiotics (not prophylaxis); wounds often left open for secondary intention or delayed primary closure.

Evidence-Based SSI Prevention Bundle

To reduce surgical site infections, the World Health Organization (WHO) and Kenya Ministry of Health mandate adherence to a strict perioperative bundle:

Preoperative Chlorhexidine Bathing: Patients should bathe with soap or chlorhexidine the night before surgery.

Hair Removal: Avoid razor shaving! Shaving causes microscopic dermal abrasions that harbor bacterial proliferation. If hair must be removed, use electric clippers with disposable heads immediately prior to surgery.

Surgical Skin Preparation: Use an alcohol-based solution of chlorhexidine gluconate ( 2 % 2\% 2% ) in 70 % 70\% 70% isopropyl alcohol . Alcohol-chlorhexidine provides superior residual antibacterial action compared to aqueous povidone-iodine.

Antimicrobial Prophylaxis Timing: Administer intravenous prophylactic antibiotics (e.g., Cefazolin 1 to 2 g 1\text{ to }2\text{ g} 1 to 2 g IV ; add Metronidazole 500 mg 500\text{ mg} 500 mg IV for colorectal or pelvic surgery) within 60 minutes prior to surgical incision (or within 120 minutes for vancomycin/fluoroquinolones). Re-dose intraoperatively if the operation exceeds two half-lives of the drug ( > 3 to 4 hours > 3\text{ to }4\text{ hours} > 3 to 4 hours for cefazolin) or if blood loss exceeds 1 , 500 mL 1,500\text{ mL} 1 , 500 mL . Discontinue prophylaxis within 24 hours post-operatively.

Maintenance of Perioperative Normothermia: Maintain core body temperature ≥ 36 ∘ C \ge 36^\circ\text{C} ≥ 3 6 ∘ C using warm air blankets. Hypothermia induces peripheral vasoconstriction, reduces tissue oxygen delivery, impairs neutrophil phagocytosis, and triples the risk of SSI.

Perioperative Glycemic Control: Maintain blood glucose < 11.1 mmol/L < 11.1\text{ mmol/L} < 11.1 mmol/L ( < 200 mg/dL < 200\text{ mg/dL} < 200 mg/dL ) in both diabetic and non-diabetic surgical patients.

2. Post-Operative Fever Timeline: "The 5 Ws"

Postoperative fever ( T ≥ 38.0 ∘ C T \ge 38.0^\circ\text{C} T ≥ 38. 0 ∘ C ) is a common clinical dilemma. The timing of fever onset relative to the day of operation provides the single most reliable diagnostic clue to its underlying etiology. +-----------------------------------------------------------------------------------+

  • | THE CLASSIC 5 Ws OF POSTOPERATIVE FEVER |
  • +-----------------------------------------------------------------------------------+
  • | DAY 1–2: WIND | Atelectasis (alveolar collapse from shallow breathing, |
  • | | hypoventilation, opioid use, thoracic/abdominal splinting). |
  • +---------------------+-------------------------------------------------------------+
  • | DAY 3: WATER | Urinary Tract Infection (catheter-associated UTI secondary |
  • | | to indwelling Foley catheters). |
  • +---------------------+-------------------------------------------------------------+
  • | DAY 5: WOUND | Surgical Site Infection (superficial or deep incisional SSI;|
  • | | classical presentation 5 to 7 days post-surgery). |
  • +---------------------+-------------------------------------------------------------+
  • | DAY 7: WALKING | Venous Thromboembolism (Deep Vein Thrombosis / Pulmonary |
  • | | Embolism driven by surgical stasis and hypercoagulability). |
  • +---------------------+-------------------------------------------------------------+
  • | DAY > 7: WONDER | Drug-Induced Fever (adverse reaction to antimicrobials, |
  • | DRUGS | heparin, or anticonvulsants) or Deep Abscess/Leak. |
  • +-----------------------------------------------------------------------------------+
  • In-Depth Clinical Evaluation by Postoperative Day

Postoperative Days 1–2: "Wind" (Atelectasis):

Mechanism: General anesthesia, muscle relaxants, diaphragmatic splinting, and opioid analgesics cause shallow tidal breathing, leading to collapse of lung alveoli in dependent lung bases.

Clinical Findings: Low-grade fever ( 38.0 ∘ C 38.0^\circ\text{C} 38. 0 ∘ C to 38.5 ∘ C 38.5^\circ\text{C} 38. 5 ∘ C ), mild tachypnea, bronchial breath sounds, and fine end-expiratory crackles at both lung bases. Chest radiograph may show basilar discoid atelectasis or be entirely normal.

Management: Chest physiotherapy, incentive spirometry (10 breaths every hour while awake), early out-of-bed ambulation, and adequate multimodal analgesia to abolish painful abdominal splinting. Antibiotics are NOT indicated for uncomplicated atelectasis.

Postoperative Day 3: "Water" (Urinary Tract Infection):

Mechanism: Catheter-associated urinary tract infection (CAUTI) following prolonged indwelling urethral catheterization. Biofilm formation along the catheter allows Escherichia coli , Klebsiella , or Enterococcus colonization.

Clinical Findings: Fever, suprapubic tenderness, dysuria, frequency, cloudy or malodorous urine.

Management: Remove the Foley catheter promptly. Obtain clean-catch or catheter-specimen urine for microscopy, culture, and sensitivity. Initiate targeted antimicrobial therapy (e.g., Nitrofurantoin, Ciprofloxacin, or Ceftriaxone depending on local hospital susceptibility patterns).

Postoperative Day 5: "Wound" (Surgical Site Infection):

Mechanism: Microbial proliferation within the surgical incision, most commonly Staphylococcus aureus (including MRSA), Enterobacteriaceae , or anaerobes.

Clinical Findings: Pain out of proportion, spreading perilesional erythema, localized edema, marked warmth, wound induration, wound dehiscence, or purulent exudate draining between sutures/staples.

Management: Immediate mechanical opening of the wound . Remove skin sutures or staples over the area of maximum fluctuance. Gently probe the incision with sterile forceps, evacuate all purulence and infected hematoma, debride non-viable fascial margins, take a deep pus swab for Gram stain and culture, irrigate generously with warm normal saline, and pack loosely with saline-moistened sterile gauze for healing by secondary intention . Systemic antibiotics are indicated only if spreading cellulitis ( > 5 cm > 5\text{ cm} > 5 cm ) or systemic signs of sepsis (hypotension, marked tachycardia) are present.

Postoperative Day 7: "Walking" (Deep Vein Thrombosis & Pulmonary Embolism):

Mechanism: Virchow's Triad—venous stasis (prolonged intraoperative and postoperative immobilization), endothelial injury (pelvic/lower extremity surgery), and hypercoagulability (surgical stress response).

Clinical Findings: Unilateral lower extremity swelling (calf circumference difference > 3 cm > 3\text{ cm} > 3 cm ), dull aching calf pain, localized warmth, tenderness along the deep venous system. If complicated by Pulmonary Embolism (PE): sudden dyspnea, pleuritic chest pain, tachypnea, tachycardia ( S 1 Q 3 T 3 S_1Q_3T_3 S 1 ​ Q 3 ​ T 3 ​ pattern on ECG), and acute hypoxemia.

Management: Diagnostic compression venous ultrasonography or CT pulmonary angiogram (CTPA). Initiate therapeutic anticoagulation with Low-Molecular-Weight Heparin (LMWH, e.g., Enoxaparin 1 mg/kg 1\text{ mg/kg} 1 mg/kg subcutaneous 12-hourly) transitioned to oral anticoagulants.

Postoperative Day > 7 > 7 > 7 : "Wonder Drugs" & Hidden Complications:

Mechanism: Hypersensitivity reactions to medications (beta-lactam antibiotics, sulfonamides, heparin-induced fever, phenytoin) or deep intra-abdominal occult complications (anastomotic dehiscence, pelvic/subphrenic abscess).

Clinical Findings: Persistent spiking fevers in a patient who appears otherwise well, accompanied by peripheral eosinophilia or maculopapular drug rash. If intra-abdominal leak: persistent tachycardia, localized peritonitis, paralytic ileus.

Management: Discontinue suspect medications. If deep collection or leak is suspected, perform an abdominal contrast-enhanced CT scan for percutaneous drainage or re-laparotomy.

3. Tetanus Prophylaxis Protocol

Tetanus is an acute, spastic neurological disease caused by the potent exotoxin produced by Clostridium tetani —an obligate anaerobic, Gram-positive, spore-forming bacillus ubiquitously distributed in soil, street dust, animal manure, and human feces.

Pathophysiology & Tetanospasmin Action

Spores enter breached skin via puncture wounds, lacerations, burns, or contaminated surgical incisions.

In the presence of anaerobic conditions (devitalized tissue, foreign bodies, ischemia, or co-existing aerobic bacterial infection consuming oxygen), spores germinate into vegetative bacilli that multiply locally without systemic tissue invasion.

The bacilli produce two exotoxins: tetanolysin (tissue hemolysin) and tetanospasmin (a potent zinc-dependent endopeptidase neurotoxin).

Tetanospasmin binds to peripheral motor nerve terminals, enters the axon via endocytosis, and migrates via retrograde intra-axonal transport to the spinal cord and brainstem.

Within the central nervous system, tetanospasmin cleaves synaptobrevin (VAMP), an essential vesicle-associated membrane protein. This cleaving prevents the exocytic release of inhibitory neurotransmitters (GABA and Glycine) from presynaptic inhibitory interneurons (Renshaw cells).

Deprived of central inhibitory control, motor neurons fire uncontrollably at high frequency, resulting in agonizing reflex muscle spasms: trismus ("lockjaw"), risus sardonicus (sardonic grin), opisthotonos (arched back), laryngospasm, and violent generalized spasms triggered by minimal auditory or visual stimuli. Autonomic hyperactivity triggers labile hypertension, tachycardia, hyperpyrexia, and cardiac arrhythmias.

Wound Risk Stratification +-----------------------------------------------------------------------------------+

  • | WOUND CLASSIFICATION FOR TETANUS |
  • +-----------------------------------+-----------------------------------------------+
  • | CLEAN, MINOR WOUNDS | TETANUS-PRONE / CONTAMINATED WOUNDS |
  • +-----------------------------------+-----------------------------------------------+
  • | - Superficial, sharp incised cuts | - Wounds contaminated with soil, feces, |
  • | (e.g., clean kitchen knife, | dirt, manure, or saliva |
  • | clean glass) | - Puncture wounds (nails, wooden splinters) |
  • | - Minimal tissue loss | - Animal or human bites |
  • | - No devitalized or crushed tissue| - Crush injuries, avulsions, blast injuries |
  • | - Presentation < 6 hours post- | - Wounds with devitalized necrotic tissue |
  • | injury | - Compound (open) fractures |
  • | - Devoid of contaminants | - Thermal, chemical, or electrical burns |
  • | | - Any wound presenting after a delay > 6 hours|
  • +-----------------------------------+-----------------------------------------------+
  • National Tetanus Prophylaxis Algorithm (Kenya MOH / WHO / CDC)

Every traumatic wound requires systematic evaluation of two parameters: (1) The nature of the wound (clean minor vs tetanus-prone), and (2) The patient's prior tetanus immunization history .

Vaccination History Clean, Minor Wound Tetanus-Prone / Contaminated Wound

Uncertain or Incomplete ( < 3 doses < 3\text{ doses} < 3 doses of TT/Pentavalent) Give Tetanus Toxoid (TT/Td) Vaccine ( 0.5 mL 0.5\text{ mL} 0.5 mL IM). Complete the 3-dose primary series ( 0 0 0 , 1 month 1\text{ month} 1 month , 6 months 6\text{ months} 6 months ).; TIG is NOT indicated. Give BOTH: ; 1. Tetanus Toxoid (TT/Td) Vaccine ( 0.5 mL 0.5\text{ mL} 0.5 mL IM), AND; 2. Human Tetanus Immunoglobulin (TIG) ( 250 to 500 IU 250\text{ to }500\text{ IU} 250 to 500 IU IM).

Fully Immunized ( ≥ 3 documented doses \ge 3\text{ documented doses} ≥ 3 documented doses with last dose within 5 years) No vaccine or TIG needed. No vaccine or TIG needed.

Fully Immunized ( ≥ 3 documented doses \ge 3\text{ documented doses} ≥ 3 documented doses with last dose 5 to 10 years ago) No vaccine or TIG needed. Give Tetanus Toxoid (TT/Td) Vaccine ( 0.5 mL 0.5\text{ mL} 0.5 mL IM) booster.; TIG is NOT indicated.

Fully Immunized ( ≥ 3 documented doses \ge 3\text{ documented doses} ≥ 3 documented doses with last dose > 10 years > 10\text{ years} > 10 years ago) Give Tetanus Toxoid (TT/Td) Vaccine ( 0.5 mL 0.5\text{ mL} 0.5 mL IM) booster.; TIG is NOT indicated. Give Tetanus Toxoid (TT/Td) Vaccine ( 0.5 mL 0.5\text{ mL} 0.5 mL IM) booster.; TIG is NOT indicated.

Mandatory Administration & Surgical Principles

Separate Syringes, Separate Sites: When administering both Tetanus Toxoid (active immunity) and Tetanus Immunoglobulin (passive immunity), you must inject them using separate syringes at completely different anatomical sites (e.g., TT in the right deltoid and TIG in the left deltoid or anterolateral thigh). Never mix TT and TIG in the same syringe or inject them into the same limb , as the circulating antibodies will bind and neutralize the vaccine toxoid, rendering the active vaccination entirely useless.

TIG Dosing: The standard prophylactic dose of Human Tetanus Immunoglobulin is 250 IU 250\text{ IU} 250 IU IM . Increase to 500 IU 500\text{ IU} 500 IU IM if the wound is heavily contaminated with soil/feces, presents after > 24 hours > 24\text{ hours} > 24 hours , or is associated with extensive tissue necrosis.

Thorough Surgical Debridement: Pharmacological prophylaxis is useless if non-viable tissue remains. Vigorously irrigate wounds with copious normal saline under pressure, debride all non-viable tissue, excise foreign bodies, and leave heavily contaminated wounds open to prevent the formation of an anaerobic environment.